Core Laboratories Stock Forecast, Price & News

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 2 sell ratings and 1 hold rating for the stock. The consensus among Wall Street research analysts is that investors should "reduce" Core Laboratories stock.
View analyst ratings for Core Laboratories or view top-rated stocks.

3 Wall Street analysts have issued 12-month price objectives for Core Laboratories' stock. Their CLB stock forecasts range from $21.30 to $35.00. On average, they anticipate Core Laboratories' stock price to reach $29.43 in the next year. This suggests a possible upside of 50.6% from the stock's current price.
View analysts' price targets for Core Laboratories or view top-rated stocks among Wall Street analysts.

Core Laboratories' stock was trading at $22.31 at the start of the year. Since then, CLB stock has decreased by 12.4% and is now trading at $19.54.
View the best growth stocks for 2022 here.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 27th 2022.
View our earnings forecast for Core Laboratories.

Core Laboratories will be holding an earnings conference call on Thursday, July 28th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

Core Laboratories (NYSE:CLB) released its quarterly earnings results on Wednesday, April, 27th. The oil and gas company reported $0.08 EPS for the quarter, beating the consensus estimate of $0.06 by $0.02. The oil and gas company had revenue of $115.30 million for the quarter, compared to the consensus estimate of $111.63 million. Core Laboratories had a net margin of 2.04% and a trailing twelve-month return on equity of 18.28%. During the same period in the previous year, the firm posted $0.15 earnings per share.
View Core Laboratories' earnings history.

Core Laboratories announced a quarterly dividend on Wednesday, April 27th. Stockholders of record on Monday, May 9th will be paid a dividend of $0.01 per share on Tuesday, May 31st. This represents a $0.04 annualized dividend and a dividend yield of 0.20%. The ex-dividend date is Friday, May 6th.
View Core Laboratories' dividend history.

Core Laboratories(NYSE:CLB) pays an annual dividend of $0.04 per share and currently has a dividend yield of 0.20%. The dividend payout ratio of Core Laboratories is 19.05%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Core Laboratories will have a dividend payout ratio of 2.99% next year. This indicates that Core Laboratories will be able to sustain or increase its dividend.
View Core Laboratories' dividend history.

Core Laboratories updated its first quarter 2022 earnings guidance on Wednesday, April, 13th. The company provided EPS guidance of $0.050-$0.080 for the period, compared to the consensus estimate of $0.200. The company issued revenue guidance of $110 million-$113 million, compared to the consensus revenue estimate of $110.23 million.

60 employees have rated Core Laboratories CEO David M. Demshur on Glassdoor.com. David M. Demshur has an approval rating of 36% among Core Laboratories' employees. This puts David M. Demshur in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Core Laboratories include ProFrac (PFHC), Subsea 7 (SUBCY), Liberty Energy (LBRT), NexTier Oilfield Solutions (NEX), RPC (RES), Expro Group (XPRO), Oceaneering International (OII), ProPetro (PUMP), Select Energy Services (WTTR), National Energy Services Reunited (NESR), Helix Energy Solutions Group (HLX), North American Construction Group (NOA), Ranger Energy Services (RNGR), CSI Compressco (CCLP) and Hurricane Energy (HRCXF).
View all of CLB's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Starbucks (SBUX), Micron Technology (MU), Chipotle Mexican Grill (CMG), Endologix (ELGX), Intel (INTC), Netflix (NFLX), AT&T (T) and Gilead Sciences (GILD).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CLB stock can currently be purchased for approximately $19.54.

Core Laboratories (NYSE:CLB) has a market capitalization of $904.86 million and generates $470.25 million in revenue each year. The oil and gas company earns $19.73 million in net income (profit) each year or $0.21 on an earnings per share basis.

Core Laboratories employs 3,700 workers across the globe.

Core Laboratories was founded in 1936.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The official website for Core Laboratories is www.corelab.com. The oil and gas company can be reached via phone at (120) 420-3191 or via email at [email protected].